Etiqueta: Tariffs

As reported by CnEVPost, BYD’s overall quarterly sales were down 1.82% YoY with passenger vehicles down 2.1%, while commercial vehicles were up 52.61%. While PHEV sales were down 23.72%, BEV sales were up 31.37%. While the Chinese market declined, overseas sales were up 146.42%. Looking deeper, the BYD brand saw the bulk of the decline, while premium brand Fang Cheng Bao stands out, with sales up 344.87% in September, driven by the Ti3 BEV and recently launched Ti7 PHEV, which have tended to be supply-constrained.However, this is BYD’s first YoY drop in sales since 2020. In a quarter when several other automakers saw increases. What’s happening?

The US is forging ahead with new measures to bar Chinese-made vehicles as well as certain software and hardware from the US market. Global automakers and their suppliers will now have to restructure their…

Chinese automakers BYD, MG, and Leapmotor hit record 9.8% hybrid sales share in Europe, shifting focus amid tariffs and EV competition.

September was the worst month of Q3 for the Chinese carmaker.

The global automotive industry in 2025 has found itself at the eye of a geopolitical storm. Major markets—including Europe, the United States, and China—have experienced heavy-handed policy interventions in the first three quarters of the year, forcing a rewrite of global supply chain rhythms. While overall vehicle sales have held relatively steady, automakers and their suppliers are seeing weaker order volumes and declining profitability.

Zacks highlights Tesla, Alphabet, Nio, XPeng, and BYD, with Tesla poised for a Q3 delivery beat fueled by Model Y updates, China demand, and renewed focus from Elon Musk.

The official local agent of the Chinese electric vehicle manufacturer BYD in Sri Lanka on Sunday advertised a plug-in hybrid version instead of a full EV that

Stocks to watch this morning include CoreWeave (CRWV), the NVIDIA (NVDA)-backed AI cloud scaler, which is rising after some big swings in recent weeks. In the pharmaceutical sector, AstraZeneca (AZN) gains as it announces plans to list in New York, while GSK (GSK) and UCB SA (UCB.BR) are up on appointing a new CEO and positive trial results, respectively. And it's a high-stakes moment for Tesla (TSLA), BYD (1211.HK) and other makers of electric vehicles, amid a global slowdown and as a $7,500 tax credit comes to an end in the US. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.

It's never ideal to hear that the world's most famous investor sold his stake of a company, but should investors follow?

It's never ideal to hear that the world's most famous investor sold his stake of a company, but should investors follow?